Page 41 - ILAE_Lectures_2015

94. Hevner RF. Brain overgrowth in disorders of RTK-PI3K-AKT signaling: a mosaic of malformations. Semin Perinatol
2015;39(1):36-43.

95. Cepeda C, Andre VM, Hauptman JS, et al. Enhanced GABAergic network and receptor function in pediatric cortical
dysplasia Type IIB compared with Tuberous Sclerosis Complex. Neurobiol Dis 2012;45:310-321.

96. Liu JY, Ellis M, Brooke-Ball H, et al. High-throughput, automated quantification of white matter neurons in mild
malformation of cortical development in epilepsy. Acta Neuropathol Commun, 2014;2:72.

97. Thom M, Blumcke I, Aronica E. Long-term epilepsy-associated tumors. Brain Pathol 2012;22:350-379.
98. Blumcke I, Luyken C, Urbach H, Schramm J, Wiestler OD. An isomorphic subtype of long-term epilepsy-associated

astrocytomas associated with benign prognosis. Acta Neuropathol (Berl) 2004;107:381-388.
99. Wang M, Tihan T, Rojiani AM, et al. Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with

features of infiltrating astrocytoma and ependymoma. J Neuropathol Exp Neurol 2005;64:875-881.
100. Cenacchi G, Giangaspero F. Emerging tumor entities and variants of CNS neoplasms. J Neuropathol Exp Neurol

2004;63:185-192.
101. Edgar MA, Rosenblum MK. Mixed glioneuronal tumors: recently described entities. Arch Pathol Lab Med

2007;131:228-233.
102. Daumas-Duport C. Dysembryoplastic neuroepithelial tumours. Brain Pathol 1993;3:283-295.
103. Honavar M, Janota I, Polkey CE. Histological heterogeneity of dysembryoplastic neuroepithelial tumour: identification

and differential diagnosis in a series of 74 cases. Histopathology 1999;34:342-356.
104. Sharma MC, Jain D, Gupta A, et al. Dysembryoplastic neuroepithelial tumor: a clinicopathological study of 32 cases.

Neurosurg Rev 2009;32:161-169; discussion 169-170.
105. Luyken C, Blumcke I, Fimmers R, et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and

tumor outcome and neurosurgical aspects. Epilepsia 2003;44:822-830.
106. Moazzam AA, Wagle N, Shiroishi MS. Malignant transformation of DNETs: a case report and literature review.

Neuroreport 2014;25(12):894-899.
107. Gonzales M, Dale S, Susman M, et al. Dysembryoplastic neuroepithelial tumor (DNT)-like oligodendrogliomas or Dnts

evolving into oligodendrogliomas: two illustrative cases. Neuropathology 2007;27:324-330.
108. Ray WZ, Blackburn SL, Casavilca-Zambrano S, et al. Clinicopathologic features of recurrent dysembryoplastic

neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature. J Neurooncol
2009;94:283-292.
107. Thom M, Toma A, An S, et al. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series
with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol
Exp Neurol 2011;70:859-878.
108. Blumcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol
Exp Neurol 2002;61:575-584.
109. Hirose T, Scheithauer BW. Mixed dysembryoplastic neuroepithelial tumor and ganglioglioma. Acta Neuropathol (Berl)
1998;95:649-654.
110. Shimbo Y, Takahashi H, Hayano M, Kumagai T, Kameyama S. Temporal lobe lesion demonstrating features of
dysembryoplastic neuroepithelial tumor and ganglioglioma: a transitional form? Clin Neuropathol 1997;16:65-68.
111. Becker AJ, Lobach M, Klein H, et al. Mutational analysis of TSC1 and TSC2 genes in gangliogliomas. Neuropathol
Appl Neurobiol 2001;27:105-114.
112. Kam R, Chen J, Blumcke I, et al. The reelin pathway components disabled-1 and p35 in gangliogliomas--a mutation
and expression analysis. Neuropathol Appl Neurobiol 2004;30:225-232.
113. Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: histopathologic
grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 2004;101:146-155.
114. de Groot M, Reijneveld JC, Aronica E, Heimans JJ. Epilepsy in patients with a brain tumour: focal epilepsy requires
focused treatment. Brain 2012;135:1002-1016.
115. Moran NF, Fish DR, Kitchen N, Shorvon S, Kendall BE, Stevens JM. Supratentorial cavernous haemangiomas and
epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry 1999;66:561-568.
116. Volk EE, Prayson RA. Hamartomas in the setting of chronic epilepsy: a clinicopathologic study of 13 cases. Hum
Pathol 1997;28:227-232.
117. Diehl B, Prayson R, Najm I, Ruggieri P. Hamartomas and epilepsy: clinical and imaging characteristics. Seizure
2003;12:307-311.
118. Gomez-Anson B, Thom M, Moran N, Stevens J, Scaravilli F. Imaging and radiological-pathological correlation in
histologically proven cases of focal cortical dysplasia and other glial and neuronoglial malformative lesions in adults.
Neuroradiology 2000;42:157-167.
119. Kerrigan JF, Ng YT, Chung S, Rekate HL. The hypothalamic hamartoma: a model of subcortical epileptogenesis and
encephalopathy. Semin Pediatr Neurol 2005;12:119-131.
120. Balestri P, Vivarelli R, Grosso S, et al. Malformations of cortical development in neurofibromatosis type 1. Neurology
2003;61:1799-1801.
121. Vivarelli R, Grosso S, Calabrese F, et al. Epilepsy in neurofibromatosis 1. J Child Neurol 2003;18:338-342.
122. Perry A, Kurtkaya-Yapicier O, Scheithauer BW, et al. Insights into meningioangiomatosis with and without
meningioma: a clinicopathologic and genetic series of 24 cases with review of the literature. Brain Pathol 2005;15:55-
65.
123. Wiebe S, Munoz DG, Smith S, Lee DH. Meningioangiomatosis. A comprehensive analysis of clinical and laboratory
features. Brain 1999;122 ( Pt 4):709-726.